FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Resumes Generic Drug In-person Meetings

FDA says that it is now resuming generic in-person face-to-face meetings with generic drug industry members in a phased-in approach while also allowin...

latest-news-card-1
Medical Devices

Alternative 510(k) Pathway for Contact Lenses

FDA makes available a final guidance entitled Soft (Hydrophilic) Daily Wear Contact Lenses Performance Criteria for Safety and Performance Based Path...

latest-news-card-1
Medical Devices

Vaporox Next-gen Wound Healer Cleared

FDA clears a Vaporox 510(k) for its next-generation VHT-200 medical device system for healing chronic wounds.

latest-news-card-1
Biologics

Iovance Biotherapeutics BLA for Melanoma Therapy

Iovance Biotherapeutics files a rolling BLA submission for lifileucel, a tumor infiltrating lymphocyte therapy for treating certain patients with adva...

latest-news-card-1
Federal Register

Draft Guide on Cancer Drug Accelerated Approvals

Federal Register notice: FDA posts a draft guidance entitled Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics.

latest-news-card-1
Federal Register

OTC Monograph Drug User Fee Rates

Federal Register notice: FDA announces the fee rates under the over-the-counter monograph drug user fee program for fiscal year 2023.

latest-news-card-1
Medical Devices

Two Final Guides on Covid-19 Device Transition

FDA issues two final guidances on transition plans for Covid-19-related medical devices that were granted emergency use authorizations or were allowed...

latest-news-card-1
Human Drugs

Accelerated Approval Guide Pushes Randomized Trials

Pushing randomized clinical trials, FDA issues a draft guidance entitled Clinical Trial Considerations to Support Accelerated Approval of Oncology The...

latest-news-card-1
Federal Register

CDER/CBER Digital Health Framework

Federal Register notice: FDA releases CDER/CBERs Framework for the Use of Digital Health Technologies in Drug and Biological Product Development.

latest-news-card-1
Biologics

Cell/Gene Therapy Post-approval Data Meeting

CBER's Office of Therapeutic Products plans a 4/27 public listening meeting to obtain feedback on methods and approaches for capturing post-approval s...